Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: MICRORNAS - BIOSYNTHESIS , . Treffer: 10
2017
Bayraktar, R; Pichler, M; Kanlikilicer, P; Ivan, C; Bayraktar, E; Kahraman, N; Aslan, B; Oguztuzun, S; Ulasli, M; Arslan, A; Calin, G; Lopez-Berestein, G; Ozpolat, B
MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Oncotarget. 2017; 8(7): 11641-11658.
Doi: 10.18632/oncotarget.14264
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Mayr, C; Beyreis, M; Wagner, A; Pichler, M; Neureiter, D; Kiesslich, T
Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Biomed Res Int. 2016; 2016(12):4805270-4805270
Doi: 10.1155/2016/4805270
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Int J Mol Sci. 2016; 17(12):
Doi: 10.3390/ijms17122011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Koller, K; Pichler, M; Koch, K; Zandl, M; Stiegelbauer, V; Leuschner, I; Hoefler, G; Guertl, B
Nephroblastomas show low expression of microR-204 and high expression of its target, the oncogenic transcription factor MEIS1.
Pediatr Dev Pathol. 2014; 17(3):169-175
Doi: 10.2350/13-01-1288-OA.1
Web of Science
PubMed
FullText
FullText_MUG
Matthaei, M; Hu, J; Kallay, L; Eberhart, CG; Cursiefen, C; Qian, J; Lackner, EM; Jun, AS
Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy.
Invest Ophthalmol Vis Sci. 2014; 55(1):216-225
Doi: 10.1167/iovs.13-12689
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rohringer, S; Holnthoner, W; Hackl, M; Weihs, AM; Rünzler, D; Skalicky, S; Karbiener, M; Scheideler, M; Pröll, J; Gabriel, C; Schweighofer, B; Gröger, M; Spittler, A; Grillari, J; Redl, H
Molecular and cellular effects of in vitro shockwave treatment on lymphatic endothelial cells.
PLoS One. 2014; 9(12):e114806-e114806
Doi: 10.1371/journal.pone.0114806
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Rommer, A; Steinleitner, K; Hackl, H; Schneckenleithner, C; Engelmann, M; Scheideler, M; Vlatkovic, I; Kralovics, R; Cerny-Reiterer, S; Valent, P; Sill, H; Wieser, R
Overexpression of primary microRNA 221/222 in acute myeloid leukemia.
BMC Cancer. 2013; 13(8):364-364
Doi: 10.1186/1471-2407-13-364
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Chan, XH; Nama, S; Gopal, F; Rizk, P; Ramasamy, S; Sundaram, G; Ow, GS; Vladimirovna, IA; Tanavde, V; Haybaeck, J; Kuznetsov, V; Sampath, P
Targeting Glioma Stem Cells by Functional Inhibition of a Prosurvival OncomiR-138 in Malignant Gliomas.
Cell Rep. 2012; 2(3):591-602
Doi: 10.1016/j.celrep.2012.07.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pichler, M; Winter, E; Stotz, M; Eberhard, K; Samonigg, H; Lax, S; Hoefler, G;
Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
Br J Cancer. 2012; 106(11):1826-1832
Doi: 10.1038/bjc.2012.175
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Jurkin, J; Schichl, YM; Koeffel, R; Bauer, T; Richter, S; Konradi, S; Gesslbauer, B; Strobl, H
miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation.
J Immunol. 2010; 184(9):4955-4965
Doi: 10.4049/jimmunol.0903021
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar